JavaScript is required to use this site. Please enable JavaScript in your browser settings.

September 27, 2022

Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial

Platzhalterbild
Previous Entry Back to Overview Next Entry
funded by:
Gefördert vom Bundesministerium für Bildung und Forschung.
Gefördert vom Freistaat Sachsen.